Status: current, Defined. Date: 31-Jul 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3824301000168118 | Capecitabine (DRLA) (capecitabine 150 mg) tablet, 60 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3824311000168115 | Capecitabine (DRLA) 150 mg tablet, 60, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Capecitabine (DRLA) 150 mg tablet, 60, blister pack | has TP | Capecitabine (DRLA) | true | Inferred relationship | Some | ||
| Capecitabine (DRLA) 150 mg tablet, 60, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Capecitabine (DRLA) 150 mg tablet, 60, blister pack | Is a | Capecitabine (DRLA) 150 mg tablet, 60 | true | Inferred relationship | Some | ||
| Capecitabine (DRLA) 150 mg tablet, 60, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Capecitabine (DRLA) 150 mg tablet, 60, blister pack | has TPUU | Capecitabine (DRLA) 150 mg tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR